Vaxart, Inc.
VXRT
$0.58
$0.022.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 87.90% | 586.46% | 1,367.93% | 520.68% | 857.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 87.90% | 586.46% | 1,367.93% | 520.68% | 857.18% |
| Cost of Revenue | -4.33% | 99.30% | 404.10% | 184.53% | 61.70% |
| Gross Profit | 199.45% | 891.12% | 65.12% | 9.69% | 41.37% |
| SG&A Expenses | -8.41% | -8.87% | -1.50% | -11.18% | -29.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.91% | 82.99% | 313.36% | 139.81% | 36.42% |
| Operating Income | 134.64% | 582.27% | 46.04% | 10.17% | 37.95% |
| Income Before Tax | 133.61% | 569.04% | 42.23% | 8.99% | 36.42% |
| Income Tax Expenses | -69.47% | 95.45% | -5.56% | -4.76% | 111.11% |
| Earnings from Continuing Operations | 133.22% | 559.28% | 42.18% | 8.99% | 36.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 133.22% | 559.28% | 42.18% | 8.99% | 36.15% |
| EBIT | 134.64% | 582.27% | 46.04% | 10.17% | 37.95% |
| EBITDA | 149.65% | 720.98% | 53.22% | 11.66% | 42.05% |
| EPS Basic | 131.43% | 542.88% | 42.49% | 26.37% | 52.70% |
| Normalized Basic EPS | 131.76% | 553.09% | 42.49% | 26.26% | 52.88% |
| EPS Diluted | 128.57% | 540.61% | 42.49% | 26.37% | 51.59% |
| Normalized Diluted EPS | 131.53% | 552.47% | 42.49% | 26.26% | 52.88% |
| Average Basic Shares Outstanding | 5.58% | 3.64% | 0.65% | 23.64% | 35.02% |
| Average Diluted Shares Outstanding | 6.26% | 3.77% | 0.65% | 23.64% | 35.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |